Salma Remtulla, Cam-Tu Emilie Nguyen, Chitra Prasad, Craig
Campbell. Twinkle-Associated
Mitochondrial DNA Depletion. Pediatric
Neurology. In press.
Abstract
Background
Autosomal recessive mutations in the nuclear Twinkle
(C10orf2) gene cause a mitochondrial DNA depletion syndrome (MDS) characterized
by early onset hepatoencephalopathy.
Methods
We report a severe, early onset encephalopathy and
multisystem failure case caused by novel recessive Twinkle gene mutations.
Patient clinical, laboratory, and pathological features are reported and
Twinkle-associated MDS literature reviewed.
Results
Typical presentation includes symptom onset before age six
months, failure to thrive, psychomotor regression, epileptic encephalopathy,
sensory axonal neuropathy, cholestatic liver dysfunction, and occasionally,
renal tubulopathy, movement disorders, and ophthalmoplegia. Death is typical
before age four years.
Conclusions
In the differential diagnosis of early onset encephalopathy
and multisystem failure, MDS should be considered.
-----------------------------------------------------------------------------------------------------
From the article:
Mitochondrial depletion syndromes (MDS) are comprised of autosomal
recessive disorders caused by mutations in nuclear genes encoding for key
enzymes involved in mitochondrial DNA (mtDNA) replication and/or maintenance.
These mutations result in decreased mtDNA copy number, leading to impaired
energy production in various tissues.
The C10orf2 gene, also called PEO1 or Twinkle, encodes the
mtDNA replicative Twinkle helicase—important for mtDNA replication. Dominant
mutations in the Twinkle gene can cause multiple mtDNA deletions and result in
chronic progressive external ophthalmoplegia or mitochondrial myopathy.
Recessive Twinkle mutations cause mtDNA depletion.
MDS are phenotypically heterogeneous and manifest clinically
as early onset encephalopathy, hepatoencephalopathy, encephalomyopathy,
infantile onset spinocerebellar ataxia, or Perrault syndrome. The hepatocerebral form of MDS is associated
with mutations in Twinkle, POLG1, DGUOK , and MPV. MDS associated with POLG1 is
known as Alpers-Huttenlocher (Alpers) syndrome…
Chromosomal microarray was performed initially with normal
results. Subsequently, a comprehensive next generation sequencing panel of 183
genes associated with muscular dystrophy and myopathy revealed two heterozygous
novel variants in the C10orf2 gene. The first variant, c.853C>T, was
reportedly the type expected to be pathogenic and results in change of an
arginine residue to a stop codon at amino acid position 285 (p.Arg285Ter),
predicted to cause premature truncation of the protein. The second variant, c1592+4A>G
is an intronic splice site variant, resulting in change from an adenine to a
guanine residue located at c.1592+4 and was predicted to alter the exon 3 donor
site with potential to alter splicing. The data were insufficient for
definitive classification and the variant classified as of unknown
significance. Sanger sequencing confirmed the results. Parental testing
revealed the p.R285* variant was paternally and the c.1592+4A>G variant
maternally inherited.
No comments:
Post a Comment